For more VICC news, visit their website »
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch.
Physical fatigue, anxiety and emotional distress are just some of the symptoms that caregivers may experience while undertaking the hard work of helping a friend or loved one cope with cancer.
Join an upcoming live Facebook Chat in which Vanderbilt-Ingram Cancer Center experts will answer your questions about hereditary cancer risk on Sept. 24 at 6 p.m.
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.